Hanmi, Bioapp Accelerate Plant-Derived Coronavirus Vaccine
Part Of Broader Multi-Biotech Push
Executive Summary
Hanmi is accelerating development of a plant-derived COVID-19 vaccine with Bioapp after successful early, the forming part of the leading South Korean pharma group’s post-pandemic business vision, which includes 'green biotech'.